Cathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial Infarction

[1]  Randall J. Lee,et al.  The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results. , 2015, International journal of cardiology.

[2]  M. Ratajczak,et al.  Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction , 2015, Stem cells translational medicine.

[3]  S. Solomon,et al.  A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial) , 2015, European heart journal.

[4]  H. Nakauchi,et al.  Supplemental Figures and Figure Legends Online Figure I Online , 2014 .

[5]  J. Leor,et al.  Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction: A First-in-Man Study , 2014, Circulation. Cardiovascular interventions.

[6]  Jason A Burdick,et al.  Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. , 2013, Biomacromolecules.

[7]  J. Burdick,et al.  Sustained Release of Engineered Stromal Cell–Derived Factor 1-&agr; From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells and Preserves Ventricular Function After Myocardial Infarction , 2013, Circulation.

[8]  Roberto Bolli,et al.  Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions , 2013, Circulation research.

[9]  M. Ratajczak,et al.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. , 2013, Stem cells and development.

[10]  J. Burdick,et al.  Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. , 2012, Biomaterials.

[11]  M. Ratajczak,et al.  The Ins and Outs of Hematopoietic Stem Cells: Studies to Improve Transplantation Outcomes , 2011, Stem Cell Reviews and Reports.

[12]  M. Ratajczak,et al.  BONE MARROW EXPRESSED ANTIMICROBIAL CATIONIC PEPTIDE LL-37 ENHANCES RESPONSIVENESS OF HEMATOPOIETIC STEM PROGENITOR CELLS TO AN SDF-1 GRADIENT AND ACCELERATES THEIR ENGRAFTMENT AFTER TRANSPLANTATION , 2011, Leukemia.

[13]  J. Suh,et al.  COMP-Ang1 stimulates HIF-1α-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. , 2011, Blood.

[14]  Richard T. Lee,et al.  Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. , 2011, Cell stem cell.

[15]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[16]  W. Koch,et al.  A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse , 2010, Circulation research.

[17]  M. Ratajczak,et al.  Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia. , 2010, Experimental hematology.

[18]  S. Rafii,et al.  Role of Cardiac Myocyte CXCR4 Expression in Development and Left Ventricular Remodeling After Acute Myocardial Infarction , 2010, Circulation research.

[19]  P. Boekstegers,et al.  NF κB Activation in Embryonic Endothelial Progenitor Cells Enhances Neovascularization via PSGL‐1 Mediated Recruitment: Novel Role for LL37 , 2009, Stem cells.

[20]  Wojciech Wojakowski,et al.  Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[21]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[22]  Winfried Brenner,et al.  111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M. Ratajczak,et al.  CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion , 2003, Journal of Molecular Histology.

[24]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[25]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[26]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[27]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[28]  Jason A Burdick,et al.  Shear‐Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo , 2015, Advanced functional materials.

[29]  S. Kitamura,et al.  Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.